+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Etafenone Market - Global Forecast 2026-2032- Product Image
Etafenone Market - Global Forecast 2026-2032- Product Image
New

Etafenone Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 191 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6015379
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The etafenone market is advancing as evolving clinical practice and commercial dynamics redefine its positioning in cardiovascular care. Senior decision-makers must navigate a transformed landscape, where regulatory shifts, innovative formulations, and modernization in manufacturing are shaping both opportunities and competitive requirements.

Market Snapshot: Etafenone Market Forecast and Growth Outlook

The etafenone market grew from USD 1.33 billion in 2025 to USD 1.43 billion in 2026. It is expected to continue growing at a CAGR of 6.69%, reaching USD 2.10 billion by 2032.

Scope & Segmentation

This report delivers a comprehensive analysis of etafenone’s presence across key therapeutic, regulatory, and commercial environments. Market coverage includes:

  • Therapeutic Applications: Anti-Anginal (including Stable and Unstable Angina) and Vasodilator Agents (with Coronary Spasm and Peripheral Vasodilation sub-segments)
  • Distribution Channels: E-Commerce Pharmacies, Hospital Pharmacies, and Retail Pharmacies
  • End User Settings: Home Care, Hospitals, and Specialty Clinics
  • Formulations: Capsules, Injectable Solutions, Oral Solutions, Tablets (including Film Coated and Immediate Release variants)
  • Geographies: Americas, EMEA (Europe, Middle East & Africa), and Asia-Pacific
  • Technological Innovation: Advanced oral and injectable delivery, digital health integration, and modular manufacturing strategies

Key Takeaways: Strategic Insights for Decision-Makers

  • Etafenone retains a clinically defined role as a vasodilator with anti-anginal properties, making it vital for specific cardiovascular subpopulations, especially where tailored therapy is required.
  • Formulation advances and digital care tools are driving higher adherence and supporting new home care models, which influence both product development and engagement strategies.
  • Modernization in manufacturing and diversified sourcing, including increased nearshoring and use of CDMOs, underpin robustness against volatility and regulatory scrutiny.
  • Segment-specific channel strategies are necessary: e-commerce channels require patient-centric support, hospital pharmacies need streamlined onboarding, and retail pharmacies depend on point-of-care assistance.
  • Regional diversity in regulatory and payer frameworks mandates market-specific commercialization tactics, from outcome-based reimbursement in the Americas to flexible pricing and distribution in Asia-Pacific and localized compliance in EMEA.

Tariff Impact: United States 2025 Policy Effects

In 2025, new United States tariff adjustments placed added cost and supply pressures across pharmaceutical supply chains, significantly impacting the sourcing and price structure of cardiovascular therapies, including etafenone. Manufacturers responded by reassessing supplier arrangements, emphasizing nearshoring, and engaging contract manufacturing partners, while distributors implemented new inventory and purchasing strategies to maintain channel alignment. Commercial and regulatory planning increasingly relies on scenario-based modeling and multisource approaches to ensure continuity for prescribers and patients.

Methodology & Data Sources

This report uses a mixed-methods approach, combining interviews with clinicians, pharmacists, and supply executives, a systematic review of regulatory documents, and clinical literature analysis. Data was cross-validated, and findings were reviewed by senior analysts for accuracy and transparency.

Why This Report Matters

  • Equips business leaders to make informed portfolio, sourcing, and channel decisions based on regional and segment-specific insights.
  • Supports strategic planning by mapping regulatory, market access, and supply chain contingencies, ensuring resilience amid changing policies and market conditions.
  • Guides clinical and commercial teams in aligning product strategies with the evolving expectations of providers, payers, and patients.

Conclusion

Etafenone remains a critical option in cardiovascular care, with its long-term relevance dependent on clinical alignment, adaptable supply chains, and regionally tuned commercialization. Strategic planning and targeted execution will secure sustained utility across diverse care settings.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Etafenone Market, by Form
8.1. Capsule
8.2. Injectable Solution
8.3. Oral Solution
8.4. Tablet
8.4.1. Film Coated
8.4.2. Immediate Release
9. Etafenone Market, by Application
9.1. Anti Anginal
9.1.1. Stable Angina
9.1.2. Unstable Angina
9.2. Vasodilator Agents
9.2.1. Coronary Spasm
9.2.2. Peripheral Vasodilation
10. Etafenone Market, by Distribution Channel
10.1. Online Pharmacies
10.2. Hospital Pharmacies
10.3. Retail Pharmacies
11. Etafenone Market, by End User
11.1. Home Care Settings
11.2. Hospitals
11.3. Specialty Clinics
12. Etafenone Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Etafenone Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Etafenone Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Etafenone Market
16. China Etafenone Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Aceto Corporation
17.6. American Custom Chemicals Corporation
17.7. Arkema S.A.
17.8. Biosynth AG
17.9. BOC Sciences
17.10. Cayman Chemical Company
17.11. ChemScene LLC
17.12. Clearsynth Labs Ltd.
17.13. Croda International Plc
17.14. Haihang Industry Co., Ltd.
17.15. Hangzhou DayangChem Co., Ltd.
17.16. Hunan Er-Kang Pharmaceutical Co., Ltd.
17.17. Jiangxi Hongyuan Chemical Co., Ltd.
17.18. Merck KGaA
17.19. Nippon Fine Chemical Co., Ltd.
17.20. Oleon NV
17.21. Parchem Fine & Specialty Chemicals, Inc.
17.22. PMC Biogenix, Inc.
17.23. Santa Cruz Biotechnology, Inc.
17.24. Shandong Chuangxin Biotechnology Co., Ltd.
17.25. Sigma-Aldrich Chemicals Private Limited
17.26. Spectrum Chemical Mfg. Corp.
17.27. Tokyo Chemical Industry Co., Ltd.
17.28. Zhejiang Wumei Biotechnology Co., Ltd.
List of Figures
FIGURE 1. GLOBAL ETAFENONE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ETAFENONE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ETAFENONE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ETAFENONE MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ETAFENONE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ETAFENONE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ETAFENONE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ETAFENONE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ETAFENONE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ETAFENONE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ETAFENONE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ETAFENONE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ETAFENONE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ETAFENONE MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ETAFENONE MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ETAFENONE MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ETAFENONE MARKET SIZE, BY INJECTABLE SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ETAFENONE MARKET SIZE, BY INJECTABLE SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ETAFENONE MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ETAFENONE MARKET SIZE, BY ORAL SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ETAFENONE MARKET SIZE, BY ORAL SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ETAFENONE MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ETAFENONE MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ETAFENONE MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ETAFENONE MARKET SIZE, BY FILM COATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ETAFENONE MARKET SIZE, BY FILM COATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ETAFENONE MARKET SIZE, BY FILM COATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ETAFENONE MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ETAFENONE MARKET SIZE, BY IMMEDIATE RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ETAFENONE MARKET SIZE, BY IMMEDIATE RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ETAFENONE MARKET SIZE, BY ANTI ANGINAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ETAFENONE MARKET SIZE, BY ANTI ANGINAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ETAFENONE MARKET SIZE, BY ANTI ANGINAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ETAFENONE MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ETAFENONE MARKET SIZE, BY STABLE ANGINA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ETAFENONE MARKET SIZE, BY STABLE ANGINA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ETAFENONE MARKET SIZE, BY UNSTABLE ANGINA, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ETAFENONE MARKET SIZE, BY UNSTABLE ANGINA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ETAFENONE MARKET SIZE, BY UNSTABLE ANGINA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ETAFENONE MARKET SIZE, BY CORONARY SPASM, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ETAFENONE MARKET SIZE, BY CORONARY SPASM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ETAFENONE MARKET SIZE, BY CORONARY SPASM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ETAFENONE MARKET SIZE, BY PERIPHERAL VASODILATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ETAFENONE MARKET SIZE, BY PERIPHERAL VASODILATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ETAFENONE MARKET SIZE, BY PERIPHERAL VASODILATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ETAFENONE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ETAFENONE MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ETAFENONE MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ETAFENONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ETAFENONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ETAFENONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ETAFENONE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ETAFENONE MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ETAFENONE MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ETAFENONE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ETAFENONE MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ETAFENONE MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ETAFENONE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ETAFENONE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ETAFENONE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ETAFENONE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ETAFENONE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ETAFENONE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ETAFENONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS ETAFENONE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. EUROPE ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. EUROPE ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 98. EUROPE ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 99. EUROPE ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. EUROPE ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 101. EUROPE ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 102. EUROPE ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. EUROPE ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. AFRICA ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. AFRICA ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 114. AFRICA ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 115. AFRICA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. AFRICA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 117. AFRICA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 118. AFRICA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. AFRICA ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ETAFENONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. ASEAN ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. ASEAN ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 131. ASEAN ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 132. ASEAN ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. ASEAN ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 134. ASEAN ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 135. ASEAN ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136. ASEAN ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. GCC ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GCC ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 139. GCC ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 140. GCC ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. GCC ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 142. GCC ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 143. GCC ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. GCC ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. BRICS ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. BRICS ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 155. BRICS ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 156. BRICS ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. BRICS ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 158. BRICS ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 159. BRICS ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. BRICS ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. G7 ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. G7 ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 163. G7 ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 164. G7 ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. G7 ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 166. G7 ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 167. G7 ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. G7 ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. NATO ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. NATO ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 171. NATO ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 172. NATO ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. NATO ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 174. NATO ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 175. NATO ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. NATO ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL ETAFENONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES ETAFENONE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. CHINA ETAFENONE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 187. CHINA ETAFENONE MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 188. CHINA ETAFENONE MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 189. CHINA ETAFENONE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. CHINA ETAFENONE MARKET SIZE, BY ANTI ANGINAL, 2018-2032 (USD MILLION)
TABLE 191. CHINA ETAFENONE MARKET SIZE, BY VASODILATOR AGENTS, 2018-2032 (USD MILLION)
TABLE 192. CHINA ETAFENONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. CHINA ETAFENONE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Etafenone market report include:
  • Aceto Corporation
  • American Custom Chemicals Corporation
  • Arkema S.A.
  • Biosynth AG
  • BOC Sciences
  • Cayman Chemical Company
  • ChemScene LLC
  • Clearsynth Labs Ltd.
  • Croda International Plc
  • Haihang Industry Co., Ltd.
  • Hangzhou DayangChem Co., Ltd.
  • Hunan Er-Kang Pharmaceutical Co., Ltd.
  • Jiangxi Hongyuan Chemical Co., Ltd.
  • Merck KGaA
  • Nippon Fine Chemical Co., Ltd.
  • Oleon NV
  • Parchem Fine & Specialty Chemicals, Inc.
  • PMC Biogenix, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Shandong Chuangxin Biotechnology Co., Ltd.
  • Sigma-Aldrich Chemicals Private Limited
  • Spectrum Chemical Mfg. Corp.
  • Tokyo Chemical Industry Co., Ltd.
  • Zhejiang Wumei Biotechnology Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages191
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.43 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.1 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Etafenone (CAS 90-54-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Etafenone (CAS 90-54-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Cardiovascular Drugs Market - Global Forecast 2026-2032 - Product Image

Cardiovascular Drugs Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Antihypertensive Drugs Market - Global Forecast 2026-2032 - Product Image

Antihypertensive Drugs Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs Market Report 2025 - Product Image

Ischemic Heart Disease (IHD) Drugs Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Ischemic Heart Disease Drugs Market Report and Forecast 2025-2034 - Product Image

Ischemic Heart Disease Drugs Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From

About the Etafenone Market

Etafenone is a cardiovascular drug used to treat angina pectoris, a type of chest pain caused by reduced blood flow to the heart. It is a type of calcium channel blocker, which works by relaxing the muscles of the heart and blood vessels, allowing for improved blood flow. Etafenone is available in both oral and intravenous forms, and is often used in combination with other medications to treat angina. Etafenone is a relatively new drug, having been approved by the US Food and Drug Administration in 2019. It is used to treat angina in patients who have not responded to other treatments, and is generally well-tolerated. The market for Etafenone is growing, as more patients are turning to this drug as an alternative to other treatments. It is becoming increasingly popular among physicians and patients alike, due to its effectiveness and safety profile. Some companies in the Etafenone market include Merck, Pfizer, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.